Ra Medical Systems, Inc. (RMED)
| Market Cap | 21.16M |
| Revenue (ttm) | 4.25M |
| Net Income (ttm) | -30.71M |
| Shares Out | 4.09M |
| EPS (ttm) | -9.98 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,020,876 |
| Open | 3.16 |
| Previous Close | 3.22 |
| Day's Range | 2.87 - 3.16 |
| 52-Week Range | 2.38 - 9.82 |
| Beta | 1.45 |
| Analysts | Buy |
| Price Target | 25.00 (+730.6%) |
| Est. Earnings Date | Nov 11, 2021 |
About RMED
Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser d...
Financial Performance
In 2020, RMED's revenue was $4.41 million, a decrease of -38.81% compared to the previous year's $7.20 million. Losses were -$36.05 million, -36.72% less than in 2019.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for RMED stock is "Buy." The 12-month stock price forecast is 25.00, which is an increase of 730.56% from the latest price.
News
Ra Medical Systems to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular diseases, announces that ma...
Ra Medical Systems Reports 2021 Second Quarter Financial Results
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing its excimer laser system to treat vascular disease, reports financ...
Ra Medical Systems Announces Sale of Pharos Dermatology Business
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing its excimer laser system to treat vascular disease, announces the s...
Ra Medical Systems to Report Second Quarter 2021 Financial Results on August 16, 2021
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report second quarter 2021 financial results after market close on Monday, August 16, 2021. Ra Me...
Ra Medical Systems Announces Progress with Guidewire-Compatible Catheter Design and Provides Update on Atherectomy Tr...
CARLSBAD, Calif.--(BUSINESS WIRE)---- $RMED #PAD--Ra Medical Systems Announces Progress with Guidewire-Compatible Catheter Design and Provides Update on Atherectomy Trial Enrollment
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Ra Medical Systems, Inc. for Potential Breaches of ...
NEW YORK, June 14, 2021 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty cl...
Chuck Royce's Firm Makes Changes to 3 Positions in May
Royce Investment Partners revealed earlier this week it reduced one position, added to another and sold out of a holding in May.
Why Did Ra Medical Systems Skyrocket Today?
Ra Medical Systems Inc. (NYSE:RMED) shares jumped higher Monday after retail traders pushed the stock higher. The stock was likely pushed as a possible short squeeze as it had a very high percentage of ...
RMED Stock: 8 Things to Know About RA Medical as Retail Investors Look for the Next AMC
RA Medical (RMED) stock is rocketing higher on Monday as retail traders on Reddit seek out their next target to send soaring. The post RMED Stock: 8 Things to Know About RA Medical as Retail Investors L...
Breaking Down Recent Reddit Target, RMED
RA Medical Systems Inc (NYSE:RMED) is shooting out of penny stock territory this morning, up 65.2% at $8.06 at last check, as the heavily shorted stock looks to be one of the latest victims of the "meme...
3 Short Squeeze Candidates Trading Under $10
Low float stocks can be some of the most volatile stocks in the market. If you mix in a short squeeze, the potential short-term gains in a low float stock can be extreme.
Why Second Sight Medical, Lucira Health, RA Medical Are Moving Today
Second Sight Medical Products, Inc. (NASDAQ: EYES), Lucira Health, Inc. (NASDAQ: LHDX) and Ra Medical Systems, Inc. (NYSE: RMED) were among the biggest health care gainers Wednesday. Second Sight Rallie...
Ra Medical Systems Reports 2021 First Quarter Financial Results
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological disease...
Earnings Outlook for Ra Medical Systems
Ra Medical Systems (NYSE:RMED) releases its next round of earnings this Tuesday, May 11. Here is Benzinga's essential guide to Ra Medical Systems's Q1 earnings report.
Ra Medical Systems to Report First Quarter 2021 Financial Results on May 11, 2021
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems to Report First Quarter 2021 Financial Results on May 11, 2021
Ra Medical Systems Provides Enrollment Update for its Pivotal Atherectomy Clinical Trial
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases...
Glancy Prongay & Murray LLP Obtains Important Ruling for Ra Medical Systems, Inc. Investors in Securities Fraud Class...
LOS ANGELES, April 14, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM"), a leading national shareholder rights law firm, announces that on March 24, 2021, the Honorable Larry Alan Burns of the ...
Ra Medical Systems Reports 2020 Fourth Quarter and Full Year Financial Results
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological disease...
Ra Medical Systems to Participate in Upcoming Virtual Investment Conferences
CARLSBAD, Calif.--(BUSINESS WIRE)---- $RMED #RothConference--Ra Medical Systems to participate in the Virtual 33rd Annual Roth Conference and Maxim Emerging Growth Conference in March.
2 Falling Knives to Catch
Wall Street recommends purchasing shares of Ra Medical Systems Inc (RMED) and Baudax Bio Inc (NASDAQ:BXRX), which sounds quite unexpected since these two equities have shown poor performance over the pr...
Ra Medical Systems to Report 2020 Fourth Quarter and Full Year Financial Results on March 16, 2021
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) announces that it will report 2020 fourth quarter and full year financial results and provide a business update after market clos...
Will Ra Medical Systems, Inc. (RMED) Report Negative Q4 Earnings? What You Should Know
Ra Medical Systems, Inc. (RMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ra Medical Systems to Present at the H.C. Wainwright Global Life Sciences Virtual Conference
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological disease...
Ra Medical Systems Appoints Susanne L. Meline to its Board of Directors
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases...
Ra Medical Systems Reports Progress with Extending DABRA Catheter Shelf Life, Completes Quality Improvement Plan
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological disease...